Anomaly raised $17 million for an AI-powered payer intelligence platform aimed at improving payer-related workflow and strategy for healthcare stakeholders. The round was led by Sound Ventures, with participation from Alumni Ventures, Link Ventures, Redesign Health, and RRE Ventures. The financing signals continued appetite for data and analytics tooling that can shorten the distance between clinical evidence generation and reimbursement execution. For biotech operators, better payer intelligence can influence coverage decisions, contracting, and access strategies across product launches. As reimbursement complexity increases, the funding adds to momentum behind enterprise healthcare AI platforms that target operational friction rather than drug efficacy directly.